Autotaxin has been shown to predict survival, disease stage and cirrhosis also in non-cholestatic conditions8,25, while the value of autotaxin as a serum marker of fibrosis varies between phenotypes, being a better predictor in viral hepatitis compared to non-alcoholic fatty liver disease26. This evidence concerns the gene ENPP2 and Cirrhosis.